This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Cholesterol drug probe widens over Vytorin concerns
In Trenton a House committee presses Merck and Schering-Plough for more data on the SEAS study linking Vytorin to possible cancer risk. The panel seeks access to the Oxford scientist Sir Richard Peto and questions about a related report to the FDA. The probe expands as lawmakers also examine delays in releasing a second Vytorin study and the drugs’ joint venture profitability.
MENTIONED IN THIS ARTICLE
Trenton
N.J
Merck & Co
Schering- Plough Corp
Merck
Schering-Plough
House Energy and Commerce Committee
Richard T. Clark
Fred Hassan
Richard Peto
Oxford University Clinical Trials Service Unit
Vytorin
Food and Drug Administration
Peto
Merck and
FDA
John Dingell
Bart Stupak
Susan Cruzan
Rosemarie Yancosek
Schering- Plough
Associated Press
New England Journal of Medicine
Yancosek
House Committee
Oxford
Senate Finance Committee